Fairvalue-Calculator Fairvalue-Calculator
EN DE

CurveBeam AI Limited (CRVAF) Fair Value & Analysis

Healthcare · US · Market cap $25.8M

Price$0.0540
Fair Value$0.0302
Upside-44.0%
Quality76/100
Evidence: Low Range $0.0302 – $0.0356

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

CurveBeam AI Limited (CRVAF) currently trades at $0.0540, while our model-based Fair Value estimate is $0.0302 — implying the stock looks roughly 44.0% overvalued today. We read business quality at 76/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and Australia. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Software visualization tools. It also provides software CurveBeam AI Autometrics for automatically segment foot and ankle datasets; Axiometrics, provides a semi-automatic measurement of the axes of rotation of the hip, femur, knee, and ankle; and TALAS, a measurement tool that semi-automatically calculate hindfoot alignment based on reproducible three-dimensional anatomical landmarks. In addition, the company offers custom web-based cloud platfor…

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -81% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is CurveBeam AI Limited (CRVAF) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0302 versus a price of $0.0540 — about −44% (overvalued). Model-based estimate, not financial advice.
What is the fair value of CRVAF?
Our 21-model fair value for CurveBeam AI Limited is $0.0302 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0540.
What is the quality score of CRVAF?
CurveBeam AI Limited has a Quality Score of 76/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.